Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
2.575
-0.185 (-6.70%)
Jan 21, 2025, 4:00 PM EST - Market closed
Intensity Therapeutics Analyst Ratings
Total Analysts
3
Consensus Rating
Strong Buy
Price Target
$8.50
Upside
+230.10%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $8.5 | Strong Buy | Initiates | $8.5 | +230.10% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +94.17% | Nov 21, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +94.17% | Oct 31, 2024 |
| Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +366.02% | Jul 11, 2024 |
| Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +366.02% | May 16, 2024 |
| Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +366.02% | Mar 21, 2024 |
| Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +366.02% | Nov 14, 2023 |
| Benchmark | Benchmark | Buy Reiterates $12 | Buy | Reiterates | $12 | +366.02% | Aug 24, 2023 |
| Benchmark | Benchmark | Buy Initiates $12 | Buy | Initiates | $12 | +366.02% | Jul 18, 2023 |